STOCK TITAN

Incyte to Report Third Quarter Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Incyte has announced its upcoming Q3 2022 financial results conference call set for 8:00 a.m. ET on November 1, 2022. The press release detailing these results will be available at 7:00 a.m. ET on the same day. Investors can join the conference using domestic and international dial-in numbers or via a live webcast, which will also be available for replay for up to ninety days. Incyte is a Wilmington-based biopharmaceutical company dedicated to addressing significant unmet medical needs.

Positive
  • None.
Negative
  • None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, November 1, 2022.

The schedule for the press release and conference call/webcast is as follows:

  • Q3 2022 Press Release: November 1, 2022 at 7:00 a.m. ET
  • Q3 2022 Conference Call: November 1, 2022 at 8:00 a.m. ET
  • Domestic Dial-In Number: 877-407-3042
  • International Dial-In Number: 201-389-0864
  • Conference ID Number: 13733379

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13733379.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Incyte Contacts

Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.com

Investors

Christine Chiou

+1 302 274 4773

cchiou@incyte.com

Source: Incyte

FAQ

When will Incyte release its Q3 2022 financial results?

Incyte will release its Q3 2022 financial results on November 1, 2022, at 7:00 a.m. ET.

What time is the Incyte Q3 2022 conference call?

The Incyte Q3 2022 conference call is scheduled for November 1, 2022, at 8:00 a.m. ET.

How can I access the Incyte Q3 2022 conference call?

The Incyte Q3 2022 conference call can be accessed via domestic dial-in at 877-407-3042 or international dial-in at 201-389-0864 using conference ID 13733379.

Will there be a replay of the Incyte conference call?

Yes, a replay of the Incyte conference call will be available for thirty days after the call.

Where can I find more information about Incyte?

More information about Incyte can be found on their investor website at Investor.Incyte.com.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.56B
188.30M
2.04%
97.86%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON